Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSigmaroc. Regulatory News (SRC)

Share Price Information for Sigmaroc. (SRC)

Share Price is delayed by 15 minutes
Get Live Data
125.90    1.10 (0.88%)
Bid:
125.70
Ask:
126.00
Spread: 0.30 (0.239%)
Market Cap: £1.40b
SRC Live PriceLast checked at - London Stock Exchange

Intraday Sigmaroc. Share Chart

Increased Santander Credit Facility and CLN Update

24 Jan 2019 12:30

RNS Number : 0365O
SigmaRoc PLC
24 January 2019
 

SigmaRoc plc / EPIC: SRC / Market: AIM / Sector: Construction & Materials

 

24 January 2019

 

SigmaRoc plc

('SigmaRoc', the 'Company' or the 'Group')

 

Increased Santander Credit Facility

Acceptance of Tender Offer and Purchase of CLNs

Intention to delist CLNs from TISE

 

SigmaRoc plc, the AIM listed buy-and-build construction materials group, is pleased to update the market on several important developments which are expected to position the Group for continued growth and deliver increased shareholder value.

 

Increase of the Santander Term Loan and Revolving Credit Facilities

 

Further to the Company's announcement of 10 December 2018, Santander UK plc ('Santander') and the Company have entered into an agreement to increase the committed credit facilities provided to the Group (the 'Santander Credit Facility') to a total amount of £34 million. The key terms of the increased facilities remain broadly similar to the originally agreed Santander Credit Facility. The Company intends to utilise the increased facilities to the purchase of £10 million 6 per cent. convertible unsecured loan notes, due January 2022, issued by the Company (the 'CLNs'), and to provide further acquisition finance for further target businesses the Company has identified.

 

Acceptance of Tender Offer, Acquisition of all CLNs and Intention to delist the CLNs from TISE

 

On 28 December 2018, the Company posted a Tender Offer Memorandum to all holders of CLNs (the 'Noteholders') to tender their entire holdings of CLNs, currently listed on The International Stock Exchange (the 'TISE') (the 'Tender Offer'). As set out in the Company's announcement of 17 January 2019, the written resolution accompanying the Tender Offer was passed by over 75 per cent. of Noteholders (the 'Written Resolution'). The purpose of the Written Resolution was to seek Noteholders' approval, pursuant to paragraph 15.1.4 of Schedule 3 of the CLN instrument to sanction the proposed purchase of all the CLNs contemplated by the Tender Offer and, where any Noteholder does not complete a tender instruction in respect of all of the CLNs held by it by 16 January 2019, to authorise any director of the Company to execute a tender instruction for and on behalf of any Noteholder.

 

Accordingly, following entry into the enlarged Santander Credit Facility, and following the passing of the Written Resolution, the Company is pleased to announce the acceptance of the tender instructions received and has exercised the powers granted pursuant to the Written Resolution to purchase 100 per cent. of the CLNs. The settlement date was 24 January 2019.

 

It is the Company's intention to then delist the CLNs from TISE as soon as practicable.

 

Max Vermorken, CEO, commented:

 

"I would like to thank all Noteholders for their support over the past two years and am grateful for the backing shown by both shareholders and Santander for the refinancing of the CLNs. The refinancing of the CLNs significantly reduces potential shareholder dilution and demonstrates confidence in our business and the ability of those who work here."

 

Further information can be found on the Company's website at www.sigmaroc.com.

 

Enquiries:

 

SigmaRoc

Tel: +44(0)207 129 7828

Max Vermorken, CEO

Strand Hanson (Nominated and Financial adviser)

Tel: +44(0)207 409 3494

James Spinney / James Dance

Berenberg (Broker)

Tel: +44(0)203 207 7800

Ben Wright / Mark Whitmore / Laure Fine

Investor Relations

Tel: +44(0)207 129 7828

Ian Osburn / Ben Feder

ir@sigmaroc.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCCKQDBBBKDBDB
Date   Source Headline
15th Jun 20267:00 amRNSShare Purchase by Director
2nd Jun 202610:27 amRNSTR-1: Notification of Major Holdings
1st Jun 20261:51 pmRNSTR-1: Notification of Major Holdings
30th Apr 20263:37 pmRNSAGM Result
30th Apr 20267:00 amRNSAGM Statement
20th Apr 20267:00 amRNSTR-1: Notification of Major Holdings
9th Apr 20263:21 pmRNSPDMR Dealing
31st Mar 20267:00 amRNSNew debt facility
26th Mar 20267:00 amRNSShare Purchases by Director
19th Mar 20267:00 amRNSShare Purchases by Directors
18th Mar 20269:55 amRNSEmployee Benefit Trust Share Purchase
16th Mar 202610:58 amRNSAnnouncement of Option and LTIP awards
16th Mar 202610:58 amRNSAnnouncement of Option and LTIP awards
16th Mar 20267:00 amRNSFull Year Results and Notice of AGM
16th Mar 20267:00 amRNSFull Year Results and Notice of AGM
10th Mar 20265:52 pmRNSTR-1: Notification of Major Holdings
10th Mar 20265:52 pmRNSTR-1: Notification of Major Holdings
3rd Mar 20268:00 amRNS-RSkreenHouse Litherm
3rd Mar 20267:00 amRNSNotice of Results
23rd Feb 20263:59 pmRNSTR-1: Notification of Major Holdings
28th Jan 20263:40 pmRNSTR-1: Notification of Major Holdings
23rd Jan 20267:00 amRNSExercise of options and sale of shares by PDMRs
19th Jan 20267:00 amRNSYear-end trading update
7th Jan 202611:25 amRNSTR-1: Notification of Major Holdings
17th Dec 20255:41 pmRNSTR-1: Notification of Major Holdings
25th Nov 202512:06 pmRNSTR-1: Notification of Major Holdings
21st Oct 20257:00 amRNSQ3 Trading Update
16th Sep 20257:00 amRNSUpdate in relation to the AMeLi project
8th Sep 20257:25 amRNSInterim Results
27th Aug 20257:00 amRNSTR-1: Notification of Major Holdings
12th Aug 20252:57 pmRNSTR-1: Notification of Major Holdings
11th Aug 20251:17 pmRNSTR-1: Notification of Major Holdings
6th Aug 20253:51 pmRNSTR-1: Notification of Major Holdings
24th Jul 20257:00 amRNSInterim Results, Analyst Briefing & Investor Pres
15th Jul 20257:00 amRNSTR-1: Notification of Major Holdings
11th Jul 20259:45 amRNSHolding(s) in Company
9th Jul 20253:16 pmRNSHolding(s) in Company
3rd Jul 20253:28 pmRNSTR-1: Notification of Major Holdings
10th Jun 20259:15 amRNS-RSeed funding of Koncrete
15th May 202511:48 amRNSDirector/PDMR Shareholding
7th May 20257:00 amRNSCapital Markets Day
1st May 20254:01 pmRNSAGM Result
1st May 20257:00 amRNSAGM Statement
25th Apr 20257:00 amRNS-RPartnership with Adaptavate
10th Apr 20252:18 pmRNSAwards under SIP to Directors and PDMRs
1st Apr 20257:00 amRNSNotice of AGM and Posting of Annual Report
20th Mar 202510:29 amRNSTR-1: Notification of Major Holdings
17th Mar 20257:01 amRNSCapital Markets Day
17th Mar 20257:00 amRNSFull Year Results
27th Feb 20257:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.